| Literature DB >> 35093097 |
Gentaro Kumagai1, Kanichiro Wada2, Sunao Tanaka2, Toru Asari2, Yohshiro Nitobe2, Yasuyuki Ishibashi2.
Abstract
PURPOSE: Although the use of intraoperative computed tomography (CT)-based navigation systems is unlikely to cause intraoperative contamination more than the use of intraoperative fluoroscopy, the association between intraoperative CT/navigation and surgical site infections (SSIs) remains unclear. We investigated the incidence of SSIs and the association between intraoperative CT/navigation and SSIs for spinal surgeries.Entities:
Keywords: Intraoperative CT; Intraoperative fluoroscopy; Spinal surgery; Surgical site infection
Mesh:
Year: 2022 PMID: 35093097 PMCID: PMC8800220 DOI: 10.1186/s13018-022-02936-6
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Flow diagram in this study. The subjects were 512 patients who underwent posterior spine surgery at our department. The incidence of the SSIs in all patients was 4.1%. The incidence of the SSIs when no imaging, C-arm only, O-arm only, or both modalities were used was 1.9%, 7.3%, 4.7%, and 8.3%, respectively
Characteristics, diagnosis, and surgical information in each technique
| Intraoperative imaging information | ||||
|---|---|---|---|---|
| No imaging ( | C-arm only ( | O-arm only ( | Both arms ( | |
| Characteristics | ||||
| Agea, years | 65.00 (54.25–75.00) | 57.00 (16.00–66.25) | 63.00 (21.0–72.00) | 64.50 (58.00–71.50) |
| Female sex, N (%) | 103 (49.5) | 27 (49.1) | 117 (54.9) | 23 (63.9) |
| BMIa, kg/m2 | 24.52 (21.87–27.84) | 22.00 (18.76–26.54) | 22.97 (20.37–26.11) | 25.32 (22.17–28.60) |
| Obesity, N (%) | 102 (49.0) | 17 (30.9) | 71 (33.3) | 20 (55.6) |
| Hypertension, N (%) | 79 (38.0) | 13 (23.6) | 70 (32.9) | 15 (41.7) |
| Diabetes, N (%) | 34 (16.3) | 9 (16.4) | 49 (20.0) | 10 (27.8) |
| Hyperlipidemia, N (%) | 11 (5.3) | 3 (5.5) | 11 (5.2) | 3 (8.3) |
| Chronic renal failure, N (%) | 12 (5.8) | 0 (0) | 3 (1.4) | 2 (5.6) |
| Steroid use, N (%) | 3 (1.4) | 1 (1.8) | 8 (3.8) | 6 (16.7) |
| Smoking, N (%) | 10 (4.8) | 5 (9.0) | 12 (5.6) | 0 (0) |
| ASA-PS ≥ 3, N (%) | 53 (25.5) | 18 (32.7) | 70 (32.9) | 9 (25.0) |
| JOA scorea | 13.50 (11.50–15.00) | 15.00 (11.00–17.00) | 14.00 (10.50–17.00) | 13.25 (11.75–15.00) |
| Diagnosis | ||||
| Trauma | ||||
| Cervical, N (%) | 1 (0.5) | 2 (3.6) | 3 (1.4) | 0 (0) |
| Thoracic, lumbar, N (%) | 3 (1.4) | 3 (5.5) | 7 (3.3) | 0 (0) |
| Degenerative disease | ||||
| Cervical, N (%) | 38 (18.3) | 9 (16.4) | 107 (50.2) | 2 (5.6) |
| Thoracic and lumbar, N (%) | 95 (45.7) | 19 (34.5) | 13 (6.1) | 31 (86.1) |
| Spinal cord tumor, N (%) | 52 (25) | 1 (1.8) | 7 (3.3) | 0 (0) |
| Spinal deformity, N (%) | 6 (2.9) | 17 (30.9) | 64 (30.0) | 3 |
| RA, N (%) | 1 (0.5) | 1 (1.8) | 7 (3.3) | 0 (0) |
| DSA, N (%) | 0 (0) | 0 (0) | 3 (1.4) | 0 (0) |
| Metastatic disease, N (%) | 1 (0.5) | 0 (0) | 2 (0.9) | 0 (0) |
| Others, N (%) | 11 (5.3) | 3 (5.5) | 0 (0) | 0 (0) |
| Surgical information | ||||
| Instrumentation, N (%) | 5 (2.4) | 51 (92.7) | 134 (62.9) | 36 (100) |
| Posterior surgery, N (%) | 208 (100) | 54 (98.2) | 210 (98.6) | 34 (94.4) |
| Number of surgical levelsa | 2.00 (1.00–3.00) | 4.00 (1.00– 7.00) | 5.00 (4.00 – 8.00) | 2.00 (1.00 – 3.00) |
| Duration of surgerya | 176.50 (123.00–257.00) | 266.00 (198.00 – 352.00) | 262.00 (181.50– 366.00) | 269.50 (225.50– 373.20) |
| Blood loss (mL)a | 95.00 (30.00–217.50 | 350.00 (150.00–810.00) | 250.00 (80.00–580.00) | 240.00 (122.25–560.00) |
BMI, body mass index; ASA-PS, American Society of Anesthesiologists Physical Status; JOA, Japanese Orthopaedic Association., RA: rheumatoid arthritis, DSA: destructive spondyloarthropathy
aValues are presented as median value and interquartile (IQR)
Fig. 2A sterile procedure of A-arm and O-arm/navigation. C-arm fitted with a sterile drape (A), positioned to acquire AP view and was covered with sterile drapes lateral view (B). The surgical area was covered with sterile drapes while scanning using the O-arm (C). Surgeons used navigation system (D). AP, anteroposterior
Characteristics of patients in each gender
| All ( | Male ( | Female ( | ||
|---|---|---|---|---|
| Agea, years | 64.00 (46.5–73.0) | 64.00 (51.0–72.0) | 63.0 (31.5–72.0) | 0.707 |
| BMIa, kg/m2 | 23.87 (20.73–27.15) | 24.40 (21.58–27.00) | 22.98 (19.83–27.15) | 0.027* |
| Obesity, N (%) | 210 (46.5) | 114 (47.1) | 96 (35.6) | 0.009# |
| Hypertension, N (%) | 177 (39.2) | 100 (41.3) | 77 (28.5) | 0.003# |
| Diabetes, N (%) | 102 (22.6) | 62 (25.6) | 40 (14.8) | 0.003# |
| Hyperlipidemia, N (%) | 28 (6.2) | 17 (7.0) | 11 (4.1) | 0.174 |
| Chronic renal failure, N (%) | 25 (5.5) | 16 (6.6) | 9 (3.3) | 0.101 |
| Steroid use, N (%) | 18 (4.0) | 6 (2.4) | 12 (4.4) | 0.337 |
| Smoking, N (%) | 27 (6.0) | 20 (8.3) | 7 (2.6) | 0.005# |
| ASA-PS ≥ 3, N (%) | 150 (33.2) | 80 (33.1) | 70 (25.9) | 0.081 |
| JOA scorea | 13.5 (11.0–16.0) | 13.5 (10.0–15.0) | 14.0 (11.5–17.0) | 0.264 |
BMI, body mass index; ASA-PS, American Society of Anesthesiologists Physical Status; JOA, Japanese Orthopaedic Association.
aValues are presented as median value and interquartile (IQR)
bSignificant differences (P < .05) between values for men and women were calculated by *Mann–Whitney U or #Chi-square test
Cases of SSIs in each techniques
| Age (years), gender | Comorbidities | Diagnosis | Surgical methods/Instrumentation | Type of SSI* | SSI bacteria | Additional surgery |
|---|---|---|---|---|---|---|
| No intraoperative imaging | ||||||
| 84, female | None | LDH | Herniotomy/No | S | N. D. | No |
| 51, male | Psoriasis | OPLL | Cervical laminoplasty/No | D | Yes | |
| 76, male | Hypertension, malignant lymphoma | LSS | Laminectomy/No | D | Yes | |
| C-arm only | ||||||
| 56, male | Athetoid cerebral palsy | CSM | Posterior fusion/Yes | S | MSSA | No |
| 66, female | Collagen disease (steroid) | Trauma | Posterior fusion/Yes | S | MSCNS MSSA | No |
| 80, male | Cancer | LSS | Posterior fusion/Yes | S | N. D. | No |
| 78, male | Hypertension, diabetes, stroke | CSM | Posterior fusion/Yes | S | N. D. | No |
| O-arm only | ||||||
| 65, male | Hypertension, diabetes, stroke | CSM | Posterior fusion/Yes | S | N. D. | No |
| 13, male | Mental retardation | Scoliosis | Posterior fusion/Yes | S | N. D. | No |
| 62, male | Cirrhosis | CSM | Posterior decompression/No | S | No | |
| 72, female | RA | Atlantoaxial subluxation | Posterior fusion/Yes | D | MSCNS | Yes |
| 48, female | Athetoid cerebral palsy | CSM | Posterior fusion/Yes | D | MSCNS | Yes |
| 66, male | OPLL | T12 burst fracture | Posterior fusion/Yes | D | MRCNS | Yes |
| 75, female | Cancer | Pseudotumor of C1 | Posterior fusion/Yes | D | MRCNS | Yes |
| 43, female | Obesity | OPLL | Posterior fusion/Yes | D | MSCNS | Yes |
| 40, male | – | Tumor of thoracic spine | Posterior fusion/Yes | D | Yes | |
| 75, female | RA | Atlantoaxial subluxation | Posterior fusion/Yes | D | MRSA | Yes |
| Both O- and C-arm used | ||||||
| 69, female | Chronic renal failure | LSS | Posterior fusion/Yes | S | MRCNS | No |
| 88, female | Hypertension | Trauma | Posterior fusion/Yes | S | N. D. | No |
| 52, female | Hypertension, diabetes, stroke, asthma | LSS | Posterior fusion/Yes | S | MRCNS | No |
SSI, surgical site infection; CSM, cervical spondylotic myelopathy; LSS, Lumbar disc herniation; LDH, lumbar spinal stenosis; OPLL, ossification of posterior longitudinal ligament; MSCNS, methicillin-sensitive coagulase-negative staphylococci; MSSA, methicillin-sensitive Staphylococcus aureus; N. D., not detected; *Type of SSI: S, superficial; D, deep SSI
Univariate and multivariate predictors of SSI in patients after spinal surgeries
| Variables | Patients with SSI ( | Patients without SSI ( | Multivariate analysis* | |||
|---|---|---|---|---|---|---|
| OR | 95% CI | |||||
| Age, years | 66.00 (54.00–75.50) | 64.00 (46.00–73.00) | 0.482 | 1.018 | 0.987–1.051 | 0.260 |
| Female sex | 10 | 260 | 0.661 | 0.987 | 0.381–2.559 | 0.979 |
| BMIa, kg/m2 | 25.00 (21.72–30.23) | 23.70 (27.70–27.10) | 0.373 | 1.042 | 0.947–1.145 | 0.400 |
| Obesity, | 10 | 200 | 0.651 | – | – | – |
| Hypertension, N (%) | 7 | 170 | 1.000 | – | – | – |
| Diabetes, N (%) | 3 | 99 | 0.780 | – | – | – |
| Hyperlipidemia | 1 | 27 | 1.000 | – | – | – |
| Chronic renal failure | 1 | 24 | 1.000 | – | – | – |
| Steroid use | 3 | 15 | 0.033# | 3.104 | 0.677–14.227 | 0.145 |
| Smoking | 0 | 27 | 0.618 | – | – | – |
| ASA-PS ≥ 3 | 11 | 139 | 0.026# | 1.878 | 0.702–5.025 | 0.209 |
| JOA scorea | 11.50 (7.00–13.50) | 13.20 (11.00–16.00) | 0.041* | 0.878 | 0.779–0.990 | 0.034 |
| C-arm use | 4 | 52 | 0.271 | 0.921 | 0.107–7.921 | 0.940 |
| O-arm use | 10 | 204 | 0.654 | 0.631 | 0.102–3.886 | 0.619 |
| Both use | 3 | 33 | 0.177 | 0.628 | 0.064–6.136 | 0.619 |
| Instrumentation | 16 | 211 | 0.003# | 6.241 | 1.113–34.985 | 0.037 |
| Number of surgical levelsa | 4.00 (2.00–5.00) | 4.00 (2.00–5.00) | 0.274 | – | – | – |
| Duration of Surgery, min | 266.00 (186.50–367.50) | 217.00 (154.25–321.75) | 0.123 | – | – | – |
| Blood loss, ml | 330.00 (90.00–725.00) | 150.00 (50.00–400.00) | 0.260 | – | – | – |
SSI, surgical site infection; OR, odds ratio; BMI, body mass index; ASA-PS, American Society of Anesthesiologists Physical Status; JOA, Japanese Orthopaedic Association. a Values are presented as median value and interquartile (IQR). bSignificant differences (P < .05) between values for patients with SSI and without SSI were calculated by *Mann–Whitney U or #Chi-square test